Search hospitals > Illinois > Chicago

University of Chicago

Claim this profile
Chicago, Illinois 60637
Global Leader in Cancer
Global Leader in Leukemia
Conducts research for Tumors
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
1389 reported clinical trials
186 medical researchers
Photo of University of Chicago in ChicagoPhoto of University of Chicago in ChicagoPhoto of University of Chicago in Chicago

Summary

University of Chicago is a medical facility located in Chicago, Illinois. This center is recognized for care of Cancer, Leukemia, Tumors, Breast Cancer, Non-Small Cell Lung Cancer and other specialties. University of Chicago is involved with conducting 1,389 clinical trials across 1,462 conditions. There are 186 research doctors associated with this hospital, such as Rita Nanda, MD, Ardaman Shergill, MD, Christine M. Bestvina, and Ami V Desai.

Area of expertise

1Cancer
Global Leader
University of Chicago has run 182 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
HER2 positive
2Leukemia
Global Leader
University of Chicago has run 145 trials for Leukemia. Some of their research focus areas include:
FLT3 positive
BCR-ABL1 positive
HLA-A positive

Top PIs

Clinical Trials running at University of Chicago

Colorectal Cancer
B-Cell Lymphoma
Liver Cancer
Cancer
Breast Cancer
Coronavirus
Lymphoma
Parkinson's Disease
Non-Small Cell Lung Cancer
Multiple Myeloma
Image of trial facility.

VS-6766 + Cetuximab

for Colorectal Cancer

This trial is testing a new drug combination (VS-6766 and cetuximab) for patients with advanced colorectal cancer who have not responded to other treatments. The combination aims to stop cancer cells from growing and make it easier for the body to fight the cancer. Cetuximab has been used in various combinations for treating advanced colorectal cancer.
Recruiting2 awards Phase 1 & 210 criteria
Image of trial facility.

Encorafenib + Cetuximab

for Colorectal Cancer

The purpose of this study is to evaluate two study medicines (encorafenib plus cetuximab) taken alone or together with standard chemotherapy for the potential treatment of colorectal cancer that: has spread to other parts of the body (metastatic); has a certain type of abnormal gene called "BRAF"; and has not received prior treatment. Participants in this study will receive one of the following study treatments: Encorafenib plus cetuximab: These participants will receive encorafenib by mouth at home every day and cetuximab once every two weeks by intravenous (IV) infusion (an injection into the vein) at the study clinic. Encorafenib plus cetuximab with chemotherapy: These participants will receive encorafenib and cetuximab in the way described in the bullet above. Additionally, they will receive standard chemotherapy by IV infusion and oral treatment at home. Chemotherapy alone: These participants will receive chemotherapy, the standard treatment for this condition, by IV infusion at the study clinics and oral treatment at home. The study team will monitor how each participant responds to the study treatment for up to about 3 years.
Recruiting2 awards Phase 310 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Chicago?
University of Chicago is a medical facility located in Chicago, Illinois. This center is recognized for care of Cancer, Leukemia, Tumors, Breast Cancer, Non-Small Cell Lung Cancer and other specialties. University of Chicago is involved with conducting 1,389 clinical trials across 1,462 conditions. There are 186 research doctors associated with this hospital, such as Rita Nanda, MD, Ardaman Shergill, MD, Christine M. Bestvina, and Ami V Desai.
Where is University of Chicago located?
**Directions to the University of Chicago Medicine Main Campus:** - **From the North:** Take the Kennedy Expressway (I-90) or Edens Expressway (I-94) south to the Dan Ryan Expressway (I-90/94) east. Exit at 55th Street (Garfield Boulevard, exit 57), turn left onto Garfield Boulevard, and continue onto Morgan Boulevard to 5841 S. Maryland Ave. - **From the West:** Take the Eisenhower Expressway (I-290) east to the Dan Ryan Expressway (I-90/I-94) east, exit at 55th Street (Garfield Boulevard, exit 57), turn left onto Garfield Boulevard, and continue onto Morgan Boulevard to 5841 S. Maryland Ave. - **From the South:** Take the Dan Ryan Expressway (I-94) north, exit at Stony Island Avenue, drive north, and turn left onto 60th Street. The campus is on your right.
Who should I call to ask about financial aid or insurance network?
**University of Chicago Hospital Financial and Insurance Assistance** - **Financial Assistance Department:** Located at 1000 Remington Boulevard, Suite 110, Bolingbrook, IL 60440. For assistance, call (773) 702-6664. - **Patient Financial Services:** For insurance inquiries, visit 150 Harvester, Ste 300, Burr Ridge, IL 60527 or call (773) 702-6664. - **Staff and Faculty Assistance Program (SFAP):** Offered through Perspectives Ltd., providing support, counseling, referrals, and resources for all life issues at no cost.
What insurance does University of Chicago accept?
The University of Chicago Medicine accepts a broad spectrum of insurance plans, including but not limited to commercial managed care, Medicare and Medicaid variants, worker's compensation, and behavioral health plans. They also cater to specific needs through transplant services insurance plans such as Aetna, Blue Distinction Centers for Transplant, Cigna LifeSource, and more. For more detailed information on accepted commercial, individual/exchange, and Medicare/Medicare Advantage plans, individuals are encouraged to directly contact their insurance provider to confirm participation before scheduling services.
What awards or recognition has University of Chicago received?
The University of Chicago Medicine is a Top Teaching Hospital, recognized by the Leapfrog Group. It has earned the Magnet Recognition Program designation for nursing excellence and the Bernard J. Tyson National Award for Excellence in Pursuit of Healthcare Equity. Additionally, twelve researchers from the institution have been awarded the Nobel Prize, underscoring its commitment to groundbreaking research.